English

Eligibility Prostate Cancer NCT00242918

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
prostate carcinoma: clinical stage t2b-3 or serum psa>20 ng/ml or gleason sum score 8-10.
Description

Prostate carcinoma TNM clinical staging | Prostate specific antigen measurement | Gleason score

Data type

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C3258246
UMLS CUI [2]
C0201544
UMLS CUI [3]
C3203027
clinical t2 patients are eligible if endorectal coil mri shows t3 disease, or gleason 4+3 cancer in 5 or more biopsies (minimum of 10 biopsies total required)
Description

TNM clinical staging | Magnetic Resonance Imaging Coils, Endorectal | Gleason score | Biopsy Quantity

Data type

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C3857139
UMLS CUI [3]
C3203027
UMLS CUI [4,1]
C0005558
UMLS CUI [4,2]
C1265611
ecog performance status of 0, 1 or 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
adequate hematological, liver and renal function
Description

Hematologic function Liver function Renal function

Data type

boolean

Alias
UMLS CUI [1,1]
C0221130
UMLS CUI [1,2]
C0232741
UMLS CUI [1,3]
C0232804
existing peripheral neuropathy < grade 1
Description

Peripheral Neuropathy CTCAE Grades

Data type

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C1516728
ability to tolerate oral medications.
Description

oral medication Receive Ability

Data type

boolean

Alias
UMLS CUI [1,1]
C0175795
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C0085732
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
concurrent or prior treatment with radiation, cytotoxic, biologic therapy for prostate cancer
Description

Therapeutic radiology procedure Prostate carcinoma | Cytotoxic therapy Prostate carcinoma | Biological treatment Prostate carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0600139
UMLS CUI [2,1]
C0677881
UMLS CUI [2,2]
C0600139
UMLS CUI [3,1]
C1531518
UMLS CUI [3,2]
C0600139
any major surgery within four weeks
Description

major surgery

Data type

boolean

Alias
UMLS CUI [1]
C0679637
prior hormonal therapy (except finasteride for obstructive voiding symptoms--evidence of metastatic disease, confirmed by physical examination, computed tomography of the abdomen and pelvis within 45 days and by bone scan within 60 days of signing informed consent
Description

Hormone Therapy | Finasteride | Voiding Disorder Obstructive | Neoplasm Metastasis | Physical Examination | CT of abdomen | Computed Tomography (CT) of Pelvis | Scan of bone | Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0279025
UMLS CUI [2]
C0060389
UMLS CUI [3,1]
C4053857
UMLS CUI [3,2]
C0549186
UMLS CUI [4]
C0027627
UMLS CUI [5]
C0031809
UMLS CUI [6]
C0412620
UMLS CUI [7]
C0412628
UMLS CUI [8]
C0203668
UMLS CUI [9]
C0021430
Back to the top of the page

Similar models

Eligibility Prostate Cancer NCT00242918

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Prostate carcinoma TNM clinical staging | Prostate specific antigen measurement | Gleason score
Item
prostate carcinoma: clinical stage t2b-3 or serum psa>20 ng/ml or gleason sum score 8-10.
boolean
C0600139 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0201544 (UMLS CUI [2])
C3203027 (UMLS CUI [3])
TNM clinical staging | Magnetic Resonance Imaging Coils, Endorectal | Gleason score | Biopsy Quantity
Item
clinical t2 patients are eligible if endorectal coil mri shows t3 disease, or gleason 4+3 cancer in 5 or more biopsies (minimum of 10 biopsies total required)
boolean
C3258246 (UMLS CUI [1])
C3857139 (UMLS CUI [2])
C3203027 (UMLS CUI [3])
C0005558 (UMLS CUI [4,1])
C1265611 (UMLS CUI [4,2])
ECOG performance status
Item
ecog performance status of 0, 1 or 2
boolean
C1520224 (UMLS CUI [1])
Hematologic function Liver function Renal function
Item
adequate hematological, liver and renal function
boolean
C0221130 (UMLS CUI [1,1])
C0232741 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
Peripheral Neuropathy CTCAE Grades
Item
existing peripheral neuropathy < grade 1
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
oral medication Receive Ability
Item
ability to tolerate oral medications.
boolean
C0175795 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Therapeutic radiology procedure Prostate carcinoma | Cytotoxic therapy Prostate carcinoma | Biological treatment Prostate carcinoma
Item
concurrent or prior treatment with radiation, cytotoxic, biologic therapy for prostate cancer
boolean
C1522449 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0677881 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
C1531518 (UMLS CUI [3,1])
C0600139 (UMLS CUI [3,2])
major surgery
Item
any major surgery within four weeks
boolean
C0679637 (UMLS CUI [1])
Hormone Therapy | Finasteride | Voiding Disorder Obstructive | Neoplasm Metastasis | Physical Examination | CT of abdomen | Computed Tomography (CT) of Pelvis | Scan of bone | Informed Consent
Item
prior hormonal therapy (except finasteride for obstructive voiding symptoms--evidence of metastatic disease, confirmed by physical examination, computed tomography of the abdomen and pelvis within 45 days and by bone scan within 60 days of signing informed consent
boolean
C0279025 (UMLS CUI [1])
C0060389 (UMLS CUI [2])
C4053857 (UMLS CUI [3,1])
C0549186 (UMLS CUI [3,2])
C0027627 (UMLS CUI [4])
C0031809 (UMLS CUI [5])
C0412620 (UMLS CUI [6])
C0412628 (UMLS CUI [7])
C0203668 (UMLS CUI [8])
C0021430 (UMLS CUI [9])
Back to the top of the page